192 related articles for article (PubMed ID: 33199729)
21. Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression.
Chou A; Chen J; Clarkson A; Samra JS; Clifton-Bligh RJ; Hugh TJ; Gill AJ
Mod Pathol; 2012 Sep; 25(9):1307-13. PubMed ID: 22555179
[TBL] [Abstract][Full Text] [Related]
22. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.
Boikos SA; Stratakis CA
Endocrine; 2014 Nov; 47(2):401-8. PubMed ID: 25027296
[TBL] [Abstract][Full Text] [Related]
23. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
[TBL] [Abstract][Full Text] [Related]
24. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
[TBL] [Abstract][Full Text] [Related]
25. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
[TBL] [Abstract][Full Text] [Related]
26. Genomic Study of Chinese Quadruple-negative GISTs Using Next-generation Sequencing Technology.
Wang S; Sun RZ; Han Q; Wang SY; Wang EH; Liu Y
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):34-41. PubMed ID: 33002893
[TBL] [Abstract][Full Text] [Related]
27. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
[TBL] [Abstract][Full Text] [Related]
28. Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing.
Hechtman JF; Zehir A; Mitchell T; Borsu L; Singer S; Tap W; Oultache A; Ladanyi M; Nafa K
Genes Chromosomes Cancer; 2015 Mar; 54(3):177-84. PubMed ID: 25427437
[TBL] [Abstract][Full Text] [Related]
29. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
[TBL] [Abstract][Full Text] [Related]
30. The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).
Nannini M; Urbini M; Astolfi A; Biasco G; Pantaleo MA
J Transl Med; 2017 May; 15(1):113. PubMed ID: 28535771
[TBL] [Abstract][Full Text] [Related]
31. A novel fusion between CDC42BPB and ALK in a patient with quadruple wild-type gastrointestinal stromal tumor.
Huang W; Yuan W; Ren L; Xu C; Luo R; Zhou Y; Lu W; Hao Q; Xu M; Hou Y
Mol Genet Genomic Med; 2022 May; 10(5):e1881. PubMed ID: 35319816
[TBL] [Abstract][Full Text] [Related]
32. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
Miettinen M; Lasota J
Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
[TBL] [Abstract][Full Text] [Related]
33. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal Stromal Tumors: The GIST of Precision Medicine.
Mei L; Smith SC; Faber AC; Trent J; Grossman SR; Stratakis CA; Boikos SA
Trends Cancer; 2018 Jan; 4(1):74-91. PubMed ID: 29413424
[TBL] [Abstract][Full Text] [Related]
36. KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.
Brcic I; Kashofer K; Skone D; Liegl-Atzwanger B
Genes Chromosomes Cancer; 2019 Nov; 58(11):798-803. PubMed ID: 31124195
[TBL] [Abstract][Full Text] [Related]
37. Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour.
Schaefer IM; Ströbel P; Cameron S; Beham A; Otto C; Schildhaus HU; Agaimy A
Histopathology; 2014 Feb; 64(3):421-30. PubMed ID: 24266839
[TBL] [Abstract][Full Text] [Related]
38. Succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Wang YM; Gu ML; Ji F
World J Gastroenterol; 2015 Feb; 21(8):2303-14. PubMed ID: 25741136
[TBL] [Abstract][Full Text] [Related]
39. Metastatic SDH-Deficient GIST Diagnosed during Pregnancy: Approach to a Complex Case.
Chennouf A; Zeidan E; Borduas M; Noël-Lamy M; Kremastiotis J; Beaudoin A
Curr Oncol; 2022 Aug; 29(8):5933-5941. PubMed ID: 36005206
[TBL] [Abstract][Full Text] [Related]
40. Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study.
Doyle LA; Nelson D; Heinrich MC; Corless CL; Hornick JL
Histopathology; 2012 Nov; 61(5):801-9. PubMed ID: 22804613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
